Evidence map›Paper›PMID 35480158›Full record

ArticleJournal of healthcare engineering2022

Prediction Model of Adverse Effects on Liver Functions of COVID-19 ICU Patients.

Aisha Mashraqi, Hanan Halawani, Turki Alelyani, Mutaib Mashraqi, Mohammed Makkawi, Sultan Alasmari, Asadullah Shaikh, Ahmad Alshehri

Open access · hybridAbstract read
In one paragraph

Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Aisha MashraqiCollege of Computer Science and Information Systems, Najran University, Najran, Saudi Arabia.ORCID 0000-0003-0449-8910
Hanan HalawaniCollege of Computer Science and Information Systems, Najran University, Najran, Saudi Arabia.ORCID 0000-0001-5050-6948
Turki AlelyaniCollege of Computer Science and Information Systems, Najran University, Najran, Saudi Arabia.ORCID 0000-0003-3583-9722
Mutaib MashraqiDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran, Saudi Arabia.ORCID 0000-0002-2931-296X
Mohammed MakkawiFaculty of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.ORCID 0000-0003-3901-7267
Sultan AlasmariFaculty of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.ORCID 0000-0003-2485-0686
Asadullah ShaikhCollege of Computer Science and Information Systems, Najran University, Najran, Saudi Arabia.ORCID 0000-0003-4806-6159
Ahmad AlshehriDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Najran University, Najran, Saudi Arabia.ORCID 0000-0002-3143-3023
Najran University · SAKing Khalid University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 is a recently discovered virus that poses an urgent threat to global health. The disease caused by this virus is termed COVID-19. Death tolls in different countries remain to rise, leading to continuous social distancing and lockdowns. Patients of different ages are susceptible to severe disease, in particular those who have been admitted to an ICU. Machine learning (ML) predictive models based on medical data patterns are an emerging topic in areas such as the prediction of liver diseases. Prediction models that combine several variables or features to estimate the risk of people being infected or experiencing a poor outcome from infection could assist medical staff in the treatment of patients, especially those that develop organ failure such as that of the liver. In this paper, we propose a model called the detecting model for liver damage (DMLD) that predicts the risk of liver damage in COVID-19 ICU patients. The DMLD model applies machine learning algorithms in order to assess the risk of liver failure based on patient data. To assess the DMLD model, collected data were preprocessed and used as input for several classifiers. SVM, decision tree (DT), Naïve Bayes (NB), KNN, and ANN classifiers were tested for performance. SVM and DT performed the best in terms of predicting illness severity based on laboratory testing.

Indexed as

COVID-19Drug-Related Side Effects and Adverse ReactionsLiver DiseasesBayes TheoremCommunicable Disease ControlHumansIntensive Care UnitsSARS-CoV-2

Identifiers

PMID35480158
PMCPMC9036165
OpenAlexW4224863211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.